Mgc Pharmaceuticals Ltd (MXC:ASX)

2.3¢

right-arrow Created with Sketch. 0 (0%)
Last trade 06.10am 25/09/2020 20mins delayed

Company Overview

MGC Pharmaceuticals Limited, formerly Erin Resources Limited, is a medical and cosmetics cannabis company. The Company is engaged in the creating cannabidiol (CBD) and medical cannabis business that focuses on the CBD market in Europe. CBD is used for the treatment of a range of skin and health conditions, including acne, psoriasis, eczema and dry skin. The Company's business model involves in growing cannabis sativa plants from high CBD yielding seeds and extracting CBD resin from the plants grown. It sells the CBD resins as a wholesale product to cosmetic and therapeutic product manufacturers. The CBD is also used to produce the Company's line of cosmetic products in Slovenia under the Ananda Cosmetics Joint Venture. It grows, harvests, dries out, extracts and sells cannabis sativa crop to enterprise customers in bulk, individual consumers in delivery devices or other products. The Company subsidiaries include MGC Pharma (UK) Ltd and MGC Pharmaceuticals d.o.o.

MXC in the news

MGC Pharma (MXC) is getting ready for over-the-counter sales of low-dose CBD…

MXC in the news

MGC Pharmaceuticals (MXC) has entered into a $15 million convertible securities financing…
MGC Pharma (MXC) has signed a joint venture (JV) agreement to register…
MGC Pharmaceuticals (MXC) says interim results from its phase two clinical trial…
Biopharma company MGC Pharmaceuticals (MXC) has signed a distribution agreement with the…